These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30353159)

  • 41. Law, history and lessons in the CRISPR patent conflict.
    Sherkow JS
    Nat Biotechnol; 2015 Mar; 33(3):256-7. PubMed ID: 25748913
    [No Abstract]   [Full Text] [Related]  

  • 42. Legal issues regarding gene editing at the beginning of life: an EU perspective.
    De Miguel Beriain I
    Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The Washington summit: orange light for genome editing?].
    Jordan B
    Med Sci (Paris); 2016 Feb; 32(2):217-20. PubMed ID: 26936181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Walk the Line: Debating a Germline Editing Moratorium.
    Davies K
    CRISPR J; 2019 Apr; 2():74-76. PubMed ID: 30998090
    [No Abstract]   [Full Text] [Related]  

  • 45. The CRISPR-baby scandal: what's next for human gene-editing.
    Cyranoski D
    Nature; 2019 Feb; 566(7745):440-442. PubMed ID: 30809070
    [No Abstract]   [Full Text] [Related]  

  • 46. The case for banning heritable genome editing.
    Botkin JR
    Genet Med; 2020 Mar; 22(3):487-489. PubMed ID: 31748711
    [No Abstract]   [Full Text] [Related]  

  • 47. China tightens rules on gene editing.
    Normile D
    Science; 2019 Mar; 363(6431):1023. PubMed ID: 30846578
    [No Abstract]   [Full Text] [Related]  

  • 48. Patent Law and Genome Engineering: A Short Guide to a Rapidly Changing Landscape.
    Cloney R
    Mol Ther; 2016 Mar; 24(3):419-21. PubMed ID: 26952920
    [No Abstract]   [Full Text] [Related]  

  • 49. CRISPR conundrum: Strict European court ruling leaves food-testing labs without a plan.
    Ledford H
    Nature; 2019 Aug; 572(7767):15. PubMed ID: 31363192
    [No Abstract]   [Full Text] [Related]  

  • 50. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Are the Argonauts lost at sea?].
    Jordan B
    Med Sci (Paris); 2017 Feb; 33(2):193-196. PubMed ID: 28240212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intellectual property education exemplified by the patents on the CRISPR/Cas9 system.
    Fan X; Liao G; Xie J
    Yi Chuan; 2014 Dec; 36(12):1269-73. PubMed ID: 25487273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene-therapy trials must proceed with caution.
    Nature; 2016 Jun; 534(7609):590. PubMed ID: 27357758
    [No Abstract]   [Full Text] [Related]  

  • 54. Genome Editing among Bioethics and Regulatory Practices.
    Mandrioli M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Law machines: scale models, forensic materiality and the making of modern patent law.
    Pottage A
    Soc Stud Sci; 2011 Oct; 41(5):621-43. PubMed ID: 22164718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene Editing Clinical Trials Could Slip through Australian Regulatory Cracks.
    Nicol D; Eckstein L
    J Law Med; 2019 Dec; 27(2):274-283. PubMed ID: 32129035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The evolution of gene patents viewed from the United States Patent Office.
    Mossinghoff GJ
    Adv Genet; 2003; 50():13-21; discussion 507-10. PubMed ID: 14714684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception.
    Hoffman DC
    Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465
    [No Abstract]   [Full Text] [Related]  

  • 59. Why Include the Public in Genome Editing Governance Deliberation?
    Blasimme A
    AMA J Ethics; 2019 Dec; 21(12):E1065-1070. PubMed ID: 31876471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome Editing, Ethics, and Politics.
    Gabel I; Moreno J
    AMA J Ethics; 2019 Dec; 21(12):E1105-1110. PubMed ID: 31876477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.